Galmed Pharmaceuticals (EOCN) Shares Outstanding (Diluted) (2013 - 2026)
Galmed Pharmaceuticals (EOCN) reported Shares Outstanding (Diluted) of 116,353 for Q2 2026, unchanged from 116,353 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
Dating back to Q1 2013, Galmed Pharmaceuticals' Shares Outstanding (Diluted) record includes 54 quarters.
- Shares Outstanding (Diluted) has a five-year compound annual growth rate of 51.1% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 116,353 in FY2024 (+303.3%), 28,848 in FY2023 (+65.2%), 17,460 in FY2022 (+2.2%) and 17,082 in FY2021 (+15.6%).
- Year over year, Shares Outstanding (Diluted) gained in five of the last eight quarters, with growth averaging 159.8%.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.0% in Q4 2025 to 303.3% in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at 116,353 (Q1 2026), 116,353 (Q4 2025) and 116,353 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Galmed Pharmaceuticals | 2.06 Mn | -38.64 Mn | - | 538,915.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 538,915.00 |
| Mar 31, 2026 | 538,915.00 |
| Dec 31, 2025 | 538,915.00 |
| Sep 30, 2025 | 116,353.00 |
| Jun 30, 2025 | 116,353.00 |
| Mar 31, 2025 | 116,353.00 |
| Dec 31, 2024 | 116,353.00 |
| Sep 30, 2024 | 346,192.00 |
| Jun 30, 2024 | 346,192.00 |
| Mar 31, 2024 | 346,192.00 |
| Dec 31, 2023 | 346,192.00 |
| Sep 30, 2023 | 3.14 Mn |
| Jun 30, 2023 | 3.14 Mn |
| Mar 31, 2023 | 3.14 Mn |
| Dec 31, 2022 | 3.14 Mn |
| Sep 30, 2022 | 3.07 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | 3.07 Mn |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | 2.66 Mn |
API Access
Galmed Pharmaceuticals Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();